Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.

Purpose: Currently, body weight-based dosing of rifampicin is recommended. But lately, fat-free mass (FFM) was reported to be superior to body weight (BW). The present evaluation aimed to assess the influence of body mass-related covariates on rifampicin's pharmacokinetics (PK) parameters in more de...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 80; no. 9; pp. 1271 - 1284
Autores principales: Bilal, Muhammad, Ullah, Sami, Jaehde, Ulrich, Trueck, Christina, Zaremba, Dario, Wachall, Bertil, Wargenau, Manfred, Scheidel, Bernhard, Wiesen, Martin H. J., Gazzaz, Malaz, Chen, Chunli, Büsker, Sören, Fuhr, Uwe, Taubert, Max, Dokos, Charalambos
Formato: equations & formulas research tables/charts Journal Article
Publicado: Springer Nature Sep2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178855709&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178855709
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Sep2024
      vid: 80
      iid: 9
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        178855709
        177123744
        178855709
        178855709
        10.1007/s00228-024-03697-3
        178855709
      ppf: 1271
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
      aug:
        au:
          Bilal, Muhammad
          Ullah, Sami
          Jaehde, Ulrich
          Trueck, Christina
          Zaremba, Dario
          Wachall, Bertil
          Wargenau, Manfred
          Scheidel, Bernhard
          Wiesen, Martin H. J.
          Gazzaz, Malaz
          Chen, Chunli
          Büsker, Sören
          Fuhr, Uwe
          Taubert, Max
          Dokos, Charalambos
        affil: Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
      sug:
        subj:
          Rifampin Pharmacokinetics
          Rifampin Administration and Dosage
          White Persons
          Volunteer Workers
          Body Composition
          Body Size
          Human
          Male
          Female
          Sex Factors
          Body Weight
          Body Height
          Descriptive Statistics
          Germany
          Body Mass Index
          Adolescence
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Body Surface Area
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Purpose: Currently, body weight-based dosing of rifampicin is recommended. But lately, fat-free mass (FFM) was reported to be superior to body weight (BW). The present evaluation aimed to assess the influence of body mass-related covariates on rifampicin's pharmacokinetics (PK) parameters in more detail using non-linear mixed effects modeling (NLMEM). Methods: Twenty-four healthy Caucasian volunteers were enrolled in a bioequivalence study, each receiving a test and a reference tablet of 600 mg of rifampicin separated by a wash-out period of at least 9 days. Monolix version 2023R1 was used for NLMEM. Monte Carlo simulations (MCS) were performed to visualize the relationship of body size descriptors to the exposure to rifampicin. Results: A one-compartment model with nonlinear (Michaelis–Menten) elimination and zero-order absorption kinetics with a lag time best described the data. The covariate model including fat-free mass (FFM) on volume of distribution (V/F) and on maximum elimination rate (Vmax/F) lowered the objective function value (OFV) by 56.4. The second-best covariate model of sex on V/F and Vmax/F and BW on V/F reduced the OFV by 51.2. The decrease in unexplained inter-individual variability on Vmax/F in both covariate models was similar. For a given dose, MCS showed lower exposure to rifampicin with higher FFM and accordingly in males compared to females with the same BW and body height. Conclusion: Our results indicate that beyond BW, body composition as reflected by FFM could also be relevant for optimized dosing of rifampicin. This assumption needs to be studied further in patients treated with rifampicin.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N